Finance

Lists
Why is 600664 up 2,10%?
Dive Deeper
600664:SHA
Harbin Pharmaceutical Group Co Ltd
6,32 CNY
+2,10%
(+0,13) 1D
16 ოქტ, 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600664...
Open
6,26 CNY
High
6,77 CNY
Low
6,19 CNY
Mkt. cap
15,59 მლრდ.
Avg. vol.
387,14 მლნ.
Volume
412,40 მლნ.
P/E ratio
31,08
52-wk high
9,86 CNY
52-wk low
2,84 CNY
EPS
0,20 CNY
Shares outstanding
2,54 მლრდ.
No. of employees
10 ათ.
Open
6,26 CNY
High
6,77 CNY
Low
6,19 CNY
Mkt. cap
15,59 მლრდ.
Avg. vol.
387,14 მლნ.
Volume
412,40 მლნ.
P/E ratio
31,08
52-wk high
9,86 CNY
52-wk low
2,84 CNY
EPS
0,20 CNY
Shares outstanding
2,54 მლრდ.
No. of employees
10 ათ.
News stories
From web sources and news partners
Profile
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate. The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
About Harbin Pharmaceutical Group Co Ltd
CEO-
Employees10 ათ.
Founded1988
Headquarters-
SectorPharmaceutical industry
Websitehayao.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
3,90 მლრდ.
3,94 მლრდ.
4,18 მლრდ.
4,12 მლრდ.
Cost of goods sold
2,95 მლრდ.
2,96 მლრდ.
3,17 მლრდ.
2,96 მლრდ.
Cost of revenue
2,95 მლრდ.
2,96 მლრდ.
3,17 მლრდ.
2,96 მლრდ.
Research and development expenses
33,63 მლნ.
51,31 მლნ.
27,02 მლნ.
33,38 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
753,48 მლნ.
815,96 მლნ.
721,16 მლნ.
803,44 მლნ.
Operating expense
838,57 მლნ.
897,00 მლნ.
786,62 მლნ.
895,87 მლნ.
Total operating expenses
3,78 მლრდ.
3,85 მლრდ.
3,96 მლრდ.
3,86 მლრდ.
Operating income
112,30 მლნ.
88,76 მლნ.
219,91 მლნ.
264,89 მლნ.
Other non operating income
468,22 ათ.
-13,01 მლნ.
-7,97 მლნ.
1,21 მლნ.
EBT including unusual items
119,12 მლნ.
91,70 მლნ.
206,43 მლნ.
311,43 მლნ.
EBT excluding unusual items
109,94 მლნ.
63,73 მლნ.
208,13 მლნ.
254,28 მლნ.
Income tax expense
41,30 მლნ.
34,62 მლნ.
45,36 მლნ.
63,42 მლნ.
Effective tax rate
34,67%
37,75%
21,97%
20,37%
Other operating expenses
24,67 მლნ.
29,19 მლნ.
21,94 მლნ.
53,95 მლნ.
Net income
68,89 მლნ.
33,00 მლნ.
161,13 მლნ.
249,19 მლნ.
Net profit margin
1,77%
0,84%
3,86%
6,05%
Earnings per share
-
-
-
-
Interest and investment income
4,05 მლნ.
3,14 მლნ.
4,20 მლნ.
6,12 მლნ.
Interest expense
-11,05 მლნ.
-10,76 მლნ.
-8,01 მლნ.
-10,10 მლნ.
Net interest expenses
-7,00 მლნ.
-7,62 მლნ.
-3,81 მლნ.
-3,98 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
166,37 მლნ.
143,03 მლნ.
274,17 მლნ.
320,66 მლნ.
Gain or loss from assets sale
3,99 მლნ.
-3,83 მლნ.
-
-35,83 მლნ.
AI content may include mistakes. Learn more
Google აპები